Rothschild Europe to lobby interests of Pfizer and Rusnano in Russia

Rothschild Europe, a group affiliated with Rothschild family, has called on the Russian government, as well as Andrei Belousov, Russia’s Presidential Aide, to provide support and assistance to the Russian nano and pharmaceutical producer Rusnano and the US drug giant Pfizer (NYSE: PFE) in their development in the Russian pharmaceutical market.

In its letter addressed to Mr Belousov, Rothschild Europe has expressed its big concerns, regarding the current regulation of public procurement of drugs in Russia, reports The Pharma Letter's local correspondent.

The biggest concerns are related to the latest amendments to the Governmental Resolution from November 2015 on limiting access of imported drugs to the public procurement in Russia. According to these amendments, starting from January 2017, foreign drugmakers are excluded from state tenders, in the case of the presence of two or more drugs produced within the territory of Russia during the procedure. In addition, the concerns are related with the provision of preferences for those drugmakers which use Russian-made substances in their production.